SCHEMBL24258243

SCHEMBL24258243

CCc1ccc(CNc2ncnc(N(Cc3ccc(C(F)(F)F)cc3)C3CC3)c2F)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.38
AURKA O14965 4/20 0.36
RPS6KB1 P23443 4/20 0.36
AURKB Q96GD4 2/20 0.36
P2RX3 P56373 4/20 0.35
P2RX2 Q9UBL9 4/20 0.35
LMNA P02545 1/20 0.35
CNR1 P21554 2/20 0.33
RORC P51449 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CNR2 P34972 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
CRHR1 P34998 1/20 0.32
CDK1 P06493 1/20 0.31
CDK2 P24941 1/20 0.31
MAPK1 P28482 1/20 0.31
MAPK8 P45983 1/20 0.31
CSNK1A1 P48729 1/20 0.31
CSNK1D P48730 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29400234 0.89 VNN1 (0.40) EGFRAURKARPS6KB1AURKBP2RX3
SCHEMBL19640698 0.89 VNN1 (0.40) EGFRAURKARPS6KB1AURKBP2RX3
SCHEMBL19650898 0.89 AURKA (0.39) EGFRAURKARPS6KB1AURKBRORC
SCHEMBL19640533 0.87 AURKA (0.42) EGFRAURKARPS6KB1AURKBRORC
SCHEMBL29401701 0.87 AURKA (0.42) EGFRAURKARPS6KB1AURKBRORC
SCHEMBL19640684 0.86 AURKA (0.38) EGFRAURKARPS6KB1AURKBP2RX3
SCHEMBL29399848 0.86 AURKA (0.38) EGFRAURKARPS6KB1AURKBP2RX3
SCHEMBL19640660 0.86 CYP3A4 (0.43) EGFRLMNAMEN1KMT2AMAPK1
SCHEMBL19640436 0.85 PTK2 (0.38) EGFRAURKARPS6KB1AURKBLMNA
SCHEMBL19640464 0.84 EGFR (0.41) EGFRAURKARPS6KB1AURKBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed